Localization of CEA, HCG, lysozyme, alpha-1-antitrypsin, and alpha-1-antichymotrypsin in gastric cancer and prognosis.
Carcinoembryonic antigen (CEA), beta-human chorionic gonadotropin (HCG), alpha-1-antichymotrypsin (ACT), alpha-1-antitrypsin (AAT) and Lysozyme (LYS) were traced by immunoperoxidase staining in gastric carcinomas. The immunohistological results were evaluated in relation to histological types (WHO and Laurén), stage of disease, grade and survival time. CEA was demonstrated in 96% of the tumours, HCG in 34%, ACT in 78%, AAT in 42%, and LYS in 71%. Comparing the staining patterns of the antigens and the intensity of staining some differences were notable. Except for signet-ring cell carcinomas, all of which were intensively positive, CEA expression decreased significantly with loss of differentiation. This observation was not seen with the other marker substances. None of the tested markers was characteristic for one particular histological type, nor could they be correlated with the tumour stage or grade. The marker positivity of CEA, ACT and LYS was not related to survival time. For HCG only, a correlation between tissue expression and a restricted survival time was established. Patients with AAT positive carcinomas had a significantly better survival probability.
D002272:Carcinoembryonic Antigen / Q000378:metabolism*; D006063:Chorionic Gonadotropin / Q000378:metabolism*; D002918:Chymotrypsin / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D007124:Immunoenzyme Techniques; D009113:Muramidase / Q000378:metabolism*; D011379:Prognosis; D013274:Stomach Neoplasms / Q000378:metabolism*; D000514:alpha 1-Antichymotrypsin; D000515:alpha 1-Antitrypsin / Q000378:metabolism*
D002272:Carcinoembryonic Antigen; D006063:Chorionic Gonadotropin; D000514:alpha 1-Antichymotrypsin; D000515:alpha 1-Antitrypsin; D009113:Muramidase; D002918:Chymotrypsin